13 result(s) for "Wound Deep"
-
1.
Wound Culture, Aerobic and Anaerobic This test is for bacterial culture of deep or complex wounds (eg, diabetic foot wounds). Both aerobic and anaerobic culture will be performed.
Key Value PROCEDURE_ID 182960 PROCEDURE_NAME CX WOUND AEROBIC/ANEROBIC ORDER_DISPLAY_NAME Wound Culture, Aerobic and Anaerobic PROCEDURE_MASTER_NUMBER LAB14028 epic_synonyms WOUND AER&ANA DEEP WOUND SURGICAL pdm 237378 cpt 87070 - culture, bacterial; aerobic 87075 - culture, bacterial; anaerobic 87205- Gram Stain If culture is positive, additional charge(s)/CPT code(s) may apply for identification and/or antibiotic susceptibilities performed when appropriate. clinical_info This test is for bacterial culture of deep or complex wounds (eg, diabetic foot wounds). Both aerobic and anaerobic culture will be performed. methodology Bacterial Culture reference_values See Report
performing_location compendium_synonyms ["Wound culture aerobic and anaerobic; deep wound; aerobe and anaerobe culture; surgical culture"] volume 39179 results [{"base_name": null, "common_name": null, "external_name": null, "component_name": null}] name Wound Culture, Aerobic and Anaerobic weight 1002 -
2.
Aspirate Culture, Aerobic and Anaerobic A wide variety of microorganisms that reside on the skin and mucous membranes of the body, as well as those found in the environment, can cause skin and soft tissue infection. The organisms enter the body through breaks in the skin or mucous membranes, through wounds made by trauma or bites (exogenous) or a complication of surgery or foreign bod...
Key Value PROCEDURE_ID 115781 PROCEDURE_NAME CX WOUND ASPIRATE ORDER_DISPLAY_NAME Aspirate Culture, Aerobic and Anaerobic PROCEDURE_MASTER_NUMBER LAB11760 epic_synonyms ASPIRATE CULTURE/GRAM STAIN SURGICAL ANAEROBE DEEP WOUND PERIOPERATIVE AEROBE STERILE DIABETIC FOOT OR CULTURE PENETRATING WOUND DIABETIC ULCER C ASP pdm 6201336 cpt 87070 - culture / 87205 - Gram stain clinical_info A wide variety of microorganisms that reside on the skin and mucous membranes of the body, as well as those found in the environment, can cause skin and soft tissue infection. The organisms enter the body through breaks in the skin or mucous membranes, through wounds made by trauma or bites (exogenous) or a complication of surgery or foreign body implants (endogenous) or they can spread through the vascular system (hematogenous). Chronic wound infections such as decubiti, foot or leg ulcers are normally due to complications related to impaired vascular flow or metabolic disease (e.g., diabetes mellitus). Aspirates obtained through intact skin by needle aspiration are the best samples for culture. The primary agents of skin and tissue infections are Staphylococcus aureus, Pseudomonas aeruginosa, members of the Enterobacterales, beta-hemolytic streptococci and anaerobes. Notes: • Gram Stain is automatically included when C ASP is ordered. • Specimens should be collected prior to initiation of antimicrobial therapy. methodology Bacterial culture and Gram Stain Routine isolation, identification procedures, and antibiotic susceptibility testing will be performed when appropriate. reference_values No growth performing_location Northwell Health Laboratories If culture is positive, additional charge(s)/CPT code(s) may apply for identification and/or antibiotic susceptibilities performed when appropriate. compendium_synonyms volume 1041 results [{"base_name": null, "common_name": null, "external_name": null, "component_name": null}] name Aspirate Culture, Aerobic and Anaerobic weight 1002 -
3.
Abscess Culture A wide variety of microorganisms that reside on the skin and mucous membranes of the body, as well as those found in the environment can cause skin and soft tissue infection. The organisms enter the body through breaks in the skin or mucous membranes, through wounds made by trauma or bites (exogenous) or a complication of surgery or foreign body...
Key Value PROCEDURE_ID 111140 PROCEDURE_NAME CULTURE - ABSCESS WITH GRAM STAIN ORDER_DISPLAY_NAME Abscess Culture PROCEDURE_MASTER_NUMBER LAB10225 epic_synonyms PUS ANAEROBIC ANAEROBE pdm 6201332 cpt 87070 - culture 87075 - anaerobic isolation and identification 87205 - Gram stain clinical_info A wide variety of microorganisms that reside on the skin and mucous membranes of the body, as well as those found in the environment can cause skin and soft tissue infection. The organisms enter the body through breaks in the skin or mucous membranes, through wounds made by trauma or bites (exogenous) or a complication of surgery or foreign body implants (endogenous) or they can be spread through the vascular system (hematogenous). Specimens should be collected prior to initial therapy and only from wounds that are clinically infected or deteriorating or fail to heal over a long period. methodology Microbiology Culture, Includes anaerobes Includes Gram stain. reference_values No growth at 5 days
performing_location Northwell Health Laboratories- LNP compendium_synonyms ["Culture - Abscess with\nGram Stain"] volume 19015 results [{"base_name": null, "common_name": null, "external_name": null, "component_name": null}] name Abscess Culture weight 1 -
4.
Wound Culture, Aerobic This test is for bacterial culture of superficial wounds. Only aerobic culture will be performed.
Key Value PROCEDURE_ID 111126 PROCEDURE_NAME CX WOUND AEROBIC ORDER_DISPLAY_NAME Wound Culture, Aerobic PROCEDURE_MASTER_NUMBER LAB10176 epic_synonyms C OTH AEROBE SUPERFICIAL WOUND pdm 237379 cpt 87070 If culture is positive, additional charge(s)/CPT code(s) may apply for identificationand/or antibiotic susceptibilities performed when appropriate. clinical_info This test is for bacterial culture of superficial wounds. Only aerobic culture will be performed. methodology Microbiology Culture This test does not include anaerobes or Gram stain. reference_values performing_location Northwell Health Laboratories compendium_synonyms ["Wound culture aerobic; superficial wound; skin wound"] volume 10359 results [{"base_name": null, "common_name": null, "external_name": null, "component_name": null}] name Wound Culture, Aerobic weight 1 -
5.
Zinc Level Monitor exposure to zinc; evaluate suspected nutritional inadequacy, especially in enteral or parental nutrition, critically ill or burn patients; cases of diabetes or delayed wound healing; growth retardation; follow therapy, for example when higher intravenous zinc doses are used to balance excessive ongoing GI losses in long-term t...
Key Value PROCEDURE_ID 64479 PROCEDURE_NAME ZINC ORDER_DISPLAY_NAME Zinc Level PROCEDURE_MASTER_NUMBER LAB581 epic_synonyms ZN pdm 5902800 cpt 84630 LONIC code: 5763-8 clinical_info Monitor exposure to zinc; evaluate suspected nutritional inadequacy, especially in enteral or parental nutrition, critically ill or burn patients; cases of diabetes or delayed wound healing; growth retardation; follow therapy, for example when higher intravenous zinc doses are used to balance excessive ongoing GI losses in long-term total parenteral nutrition; follow oral zinc therapy in Wilson's disease; confirm acrodermatitis enteropathica and follow therapy methodology Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) reference_values Age
Male
Female
0 to 2 m
50–123
50–123
3 to 4 m
44–133
51–124
5 to 10 m
49–134
49–134
≥11 m
44–115
44–115
Chronic oral zinc supplementation interferes with copper absorption and may precipitate copper deficiency. Albumin is the primary zinc binding protein: zinc levels should be interpreted with awareness of serum albumin level.
performing_location LabCorp of America compendium_synonyms volume 10010 results [{"base_name": "ZINC", "common_name": "ZINC", "external_name": "Zinc", "component_name": "ZINC LEVEL, PLASMA"}] name Zinc Level weight 1 -
6.
Tissue Culture, Aerobic and Anaerobic with Gram Stain Tissue collected during surgery are the best specimens for culture. Swab specimens are suboptimal but will be accepted if a fresh tissue specimen is not available. Specimens should be collected prior to initial therapy and only from wounds that are clinically infected or deteriorating or fail to heal over a long period.
Key Value PROCEDURE_ID 1190 PROCEDURE_NAME CX TISSUE ORDER_DISPLAY_NAME Tissue Culture, Aerobic and Anaerobic with Gram Stain PROCEDURE_MASTER_NUMBER LAB271 epic_synonyms LUNG CARTILAGE CULTURE VALVE BIOPSY CULTURE BONE CULTURE ENDOCARDITIS CULTURE - TISSUE WITH GRAM STAIN OSTEOMYELITIS pdm 6201175 cpt 87070 - culture 87075 - anaerobic identification 87205 - Gram stain clinical_info Tissue collected during surgery are the best specimens for culture. Swab specimens are suboptimal but will be accepted if a fresh tissue specimen is not available. Specimens should be collected prior to initial therapy and only from wounds that are clinically infected or deteriorating or fail to heal over a long period. methodology Microbiology Culture, Includes Gram stain, and anaerobes. reference_values Reference Values
No growth at 5 days
performing_location Northwell Health Laboratories compendium_synonyms ["Culture - Tissue with Gram Stain"] volume 8214 results [{"base_name": null, "common_name": null, "external_name": null, "component_name": null}] name Tissue Culture, Aerobic and Anaerobic with Gram Stain weight 1 -
7.
Fibrin Split Products
Key Value PROCEDURE_ID 64661 PROCEDURE_NAME FIBRIN SPLIT PRODUCTS ORDER_DISPLAY_NAME Fibrin Split Products PROCEDURE_MASTER_NUMBER LAB761 epic_synonyms DIC FSP FIBRINOLYSIS pdm 5500593 cpt 85362 clinical_info methodology Latex Agglutination/Manual (semi-quantitative) reference_values <5 µg/mL
Interpretation:
Under normal conditions, the fibrinolytic process is localized on the fibrin clots because alpha2-antiplasmin and the plasminogen activator inhibitors prevent fibrinolysis from spreading. During disseminated intravascular coagulation (DIC), fibrinolysis spreads and becomes systemic, in which case the degradation of circulating fibrinogen will occur. Fragments that occur are very heterogeneous: products derived from fibrin, soluble completes, degradation products from fibrinogen, and from nonstabilized fibrin. An abnormal fibrinolytic and/or fibrinogenolytic activity shown by high levels of FDP in plasma can also be found in clinical states, such as eclampsia, carcinoma (promyelocytic leukemia), postoperative complications, cardiac and renal disorders, hepatic disorders, fibrinolysis, pulmonary embolism, and deep vein thrombosis (DVT). Positive result indicates the presence of FDP at a concentration ≥2.5 mg/mL. This test should not be used to rule out venous thromboembolism.performing_location Northwell Health Laboratories compendium_synonyms volume 640 results [{"base_name": "FIBRINSPLPRO", "common_name": "FIBRIN SPLIT PRODUCTS", "external_name": "Fibrin Split Products", "component_name": "FIBRIN SPLIT PRODUCTS"}] name Fibrin Split Products weight 1 -
8.
Transforming Growth Factor beta1 Transforming Growth Factor (TGF) plays a crucial role in tissue regeneration, cell differentiation, embryonic development, and regulation of the immune system. Transforming growth factor beta is found in hematopoietic (blood-forming) tissue and initiates a signaling pathway that suppresses the early development of cancer cells. It enhances the ...
Key Value PROCEDURE_ID 114798 PROCEDURE_NAME TRANSFORMING GROWTH FACTOR BETA1 ORDER_DISPLAY_NAME Transforming Growth Factor beta1 PROCEDURE_MASTER_NUMBER LAB11211 epic_synonyms TGFB1 pdm 225237 cpt 83520 LOINC Code: 49853-5 clinical_info Transforming Growth Factor (TGF) plays a crucial role in tissue regeneration, cell differentiation, embryonic development, and regulation of the immune system. Transforming growth factor beta is found in hematopoietic (blood-forming) tissue and initiates a signaling pathway that suppresses the early development of cancer cells. It enhances the deposition of extracellular matrix and may play potential role in wound healing and cirrhosis formation. methodology Quantitative Enzyme-Linked Immunosorbent Assay reference_values 16542-50426 pg/mL
performing_location ARUP Laboratories compendium_synonyms volume 150 results [{"base_name": "TRANSGWTHF", "common_name": "TRANSFORMING GROWTH FACTOR BETA1", "external_name": "Transforming Growth Factor beta1", "component_name": "TRANSFORMING GROWTH FACTOR BETA1"}] name Transforming Growth Factor beta1 weight 1 -
9.
Teichoic Acid Antibodies
Key Value PROCEDURE_ID 114882 PROCEDURE_NAME TEICHOIC ACID ANTIBODIES ORDER_DISPLAY_NAME Teichoic Acid Antibodies PROCEDURE_MASTER_NUMBER LAB11256 epic_synonyms TAA pdm 5912114 cpt 86329
Loinc Code: 10358-0clinical_info methodology Semi-Quantitative Immunodiffusion reference_values Not Detected
Interpretive Data: Titer of 1:2 or greater indicate possible deep-seated S.aureus infection.
performing_location ARUP Laboratories compendium_synonyms volume 89 results [{"base_name": "TEICHACID", "common_name": "TEICHOIC ACID ANTIBODIES, SERUM", "external_name": "Teichoic Acid Antibodies", "component_name": "TEICHOIC ACID ANTIBODIES, SERUM"}] name Teichoic Acid Antibodies weight 1 -
10.
Matrix Metalloproteinase-9 MMP-9 is a marker of inflammation, tissue remodeling, wound healing, and mobilization of tissue-bound growth factors and cytokines. Its expression correlates with abnormal collagen deposition accompanying pancreatic cancer, with lymph node metastasis in breast cancer and with regional vessel invasion by giant cell tumor or bone. MMP-9 contribute...
Key Value PROCEDURE_ID 114618 PROCEDURE_NAME MATRIX METALLOPROTEINASE-9 ORDER_DISPLAY_NAME Matrix Metalloproteinase-9 PROCEDURE_MASTER_NUMBER LAB11114 epic_synonyms MMP9 pdm 1759239 cpt 83520 clinical_info MMP-9 is a marker of inflammation, tissue remodeling, wound healing, and mobilization of tissue-bound growth factors and cytokines. Its expression correlates with abnormal collagen deposition accompanying pancreatic cancer, with lymph node metastasis in breast cancer and with regional vessel invasion by giant cell tumor or bone. MMP-9 contributes to the pathogenesis of numerous clinical disease states, including rheumatic arthritis, coronary artery disease, chronic obstructive pulmonary disease, multiple sclerosis, asthma, and cancer. methodology Enzyme-linked immunosorbent assay (ELISA) reference_values 0−983 ng/mL
Results for this test are for research purposes only by the assay's manufacturer. The performance characteristics of this product have not been established. Results should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure.performing_location LabCorp compendium_synonyms volume 46 results [{"base_name": "METALPRO", "common_name": "MATRIX METALLOPROTEINASE 9", "external_name": "Matrix Metalloproteinase-9", "component_name": "MATRIX METALLOPROTEINASE-9"}] name Matrix Metalloproteinase-9 weight 1 -
11.
Prenatal HBB Full Gene Sequencing Use for prenatal analysis. Can confirm a clinical diagnosis of B-thalassemia, detect carriers, and help to establish a prognosis.
Key Value PROCEDURE_ID 192047 PROCEDURE_NAME B-THALASSEMIA; HBB PRENATAL TEST (FULL GENE SEQUENCING) ORDER_DISPLAY_NAME Prenatal HBB Full Gene Sequencing PROCEDURE_MASTER_NUMBER LAB4187 epic_synonyms HBBPRENATAL pdm 245607 cpt 31834 LOINC Code: 21689-5 clinical_info Use for prenatal analysis. Can confirm a clinical diagnosis of B-thalassemia, detect carriers, and help to establish a prognosis. methodology DNA Sequencing reference_values Normal equals reference sequencing or variants that are known or predicted to be benign;
Abnormal equals all other variants.
Limitations
This method does not reliably detect mosaic variants; large deletions; large duplications, inversions, or other rearrangements; deep intronic variants; it may be affected by allele-dropout; it may not allow determination of the exact numbers of T/A or microsatellite repeats; and it does not allow any conclusion as to whether two heterozygous variants are present on the same or on different chromosome copies.
performing_location compendium_synonyms ["HBB"] volume 6 results [{"base_name": "ROUTING", "common_name": "ROUTING", "external_name": "Routing", "component_name": "ROUTING"}] name Prenatal HBB Full Gene Sequencing weight 1 -
12.
Rivaroxaban, Anti Xa Rivaroxaban is an oral factor Xa inhibitor that is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also indicated for the treatment, prophylaxis, or the reduction in the risk of reoccurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE). Rivaroxaban does not need to ...
Key Value PROCEDURE_ID 114760 PROCEDURE_NAME RIVAROXABAN (XARELTO) LEVEL ORDER_DISPLAY_NAME Rivaroxaban, Anti Xa PROCEDURE_MASTER_NUMBER LAB11192 epic_synonyms ANTIXA XERELTO pdm 1759180 cpt 80299 LOINC Code - 72624-0 clinical_info Rivaroxaban is an oral factor Xa inhibitor that is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also indicated for the treatment, prophylaxis, or the reduction in the risk of reoccurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE). Rivaroxaban does not need to be monitored routinely, however, exceptions may include determination of failure of therapy vs. poor compliance, or potential dose adjustment required for renal or hepatic dysfunction. methodology Chromogenic reference_values Dosage Peak mcg/L
(at steady state)Trough* mcg/L 20 mg qD 182-408 3-153 15 mg qD 180-408 2-161 10 mg qD 91-196 1-38 *The lower limit of detection for this assay is 30 mcg/L. The ranges are based on literature references
performing_location Quest Diagnostics' Nichols Institute, Inc. - Chantilly compendium_synonyms ["\n\t\t\t\t\t"] volume 4 results [{"base_name": "RIVAROX", "common_name": "RIVAROXABAN XARELTO", "external_name": "Rivaroxaban (Xarelto)", "component_name": "RIVAROXABAN(XARELTO)"}] name Rivaroxaban, Anti Xa weight 1 -
13.
Miscellaneous Container
Key Value PROCEDURE_ID 192999 PROCEDURE_NAME MISCELLANEOUS CONTAINER ORDER_DISPLAY_NAME Miscellaneous Container PROCEDURE_MASTER_NUMBER LAB14582 epic_synonyms Extra Wound container Extra Unsolicited specimen pdm 251284 cpt clinical_info methodology reference_values performing_location compendium_synonyms [""] volume results [{"base_name": null, "common_name": null, "external_name": null, "component_name": null}] name Miscellaneous Container weight 1